Studies on oncogenic properties of Epstein-Barr virus.
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000032:analysis; D001769:Blood; D002175:Candida / Q000276:immunology; D002474:Cell-Free System; D002478:Cells, Cultured; D003168:Complement Fixation Tests; D004247:DNA / Q000096:biosynthesis; D005455:Fluorescent Antibody Technique; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology / Q000528:radiation effects; D051379:Mice; D008970:Molecular Weight; D009368:Neoplasm Transplantation; D009858:Oncogenic Viruses; D011830:Radiation Effects; D013539:Simian virus 40 / Q000276:immunology; D014183:Transplantation, Heterologous; D014470:Umbilical Cord
D000914:Antibodies, Viral; D000956:Antigens, Viral; D004247:DNA